SINOVAC BIOTECH LTD Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sinovac Biotech Ltd quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2023.
  • Sinovac Biotech Ltd Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $45.5M, a 22.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $45.5M -$13.1M -22.3% Dec 31, 2023 20-F 2024-04-29
Q4 2022 $58.6M -$56.8M -49.2% Dec 31, 2022 20-F 2024-04-29
Q4 2021 $115M +$31.5M +37.6% Dec 31, 2021 20-F 2023-05-01
Q4 2020 $83.8M +$77.2M +1163% Dec 31, 2020 20-F 2022-04-29
Q4 2019 $6.64M +$6.64M Dec 31, 2019 20-F 2021-04-22
Q4 2018 $0 Dec 31, 2018 20-F 2020-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.